A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence
Clinical trial NCT04949399 · COMPLETED
Trial details
- NCT number
- NCT04949399
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2022-12-20
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.